172 related articles for article (PubMed ID: 19222117)
1. In vivo anti-cancer activity of Korean Angelica gigas and its major pyranocoumarin decursin.
Lee HJ; Lee HJ; Lee EO; Lee JH; Lee KS; Kim KH; Kim SH; Lü J
Am J Chin Med; 2009; 37(1):127-42. PubMed ID: 19222117
[TBL] [Abstract][Full Text] [Related]
2. Anti-cancer and other bioactivities of Korean Angelica gigas Nakai (AGN) and its major pyranocoumarin compounds.
Zhang J; Li L; Jiang C; Xing C; Kim SH; Lü J
Anticancer Agents Med Chem; 2012 Dec; 12(10):1239-54. PubMed ID: 22583405
[TBL] [Abstract][Full Text] [Related]
3. Quantitative determination of decursin, decursinol angelate, and decursinol in mouse plasma and tumor tissue using liquid-liquid extraction and HPLC.
Li L; Zhang J; Shaik AA; Zhang Y; Wang L; Xing C; Kim SH; Lü J
Planta Med; 2012 Feb; 78(3):252-9. PubMed ID: 22116603
[TBL] [Abstract][Full Text] [Related]
4. Pyranocoumarin Tissue Distribution, Plasma Metabolome and Prostate Transcriptome Impacts of Sub-Chronic Exposure to Korean Angelica Supplement in Mice.
Zhang J; Li L; Tang S; Zhang Y; Markiewski M; Xing C; Jiang C; Lü J
Am J Chin Med; 2016; 44(2):321-53. PubMed ID: 27080944
[TBL] [Abstract][Full Text] [Related]
5. Single oral dose pharmacokinetics of decursin, decursinol angelate, and decursinol in rats.
Li L; Zhang J; Xing C; Kim SH; Lü J
Planta Med; 2013 Mar; 79(3-4):275-80. PubMed ID: 23364885
[TBL] [Abstract][Full Text] [Related]
6. Chemopreventive Effects of Korean Angelica versus Its Major Pyranocoumarins on Two Lineages of Transgenic Adenocarcinoma of Mouse Prostate Carcinogenesis.
Tang SN; Zhang J; Wu W; Jiang P; Puppala M; Zhang Y; Xing C; Kim SH; Jiang C; Lü J
Cancer Prev Res (Phila); 2015 Sep; 8(9):835-44. PubMed ID: 26116406
[TBL] [Abstract][Full Text] [Related]
7. Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway.
Jung MH; Lee SH; Ahn EM; Lee YM
Carcinogenesis; 2009 Apr; 30(4):655-61. PubMed ID: 19228635
[TBL] [Abstract][Full Text] [Related]
8. Potent antiandrogen and androgen receptor activities of an Angelica gigas-containing herbal formulation: identification of decursin as a novel and active compound with implications for prevention and treatment of prostate cancer.
Jiang C; Lee HJ; Li GX; Guo J; Malewicz B; Zhao Y; Lee EO; Lee HJ; Lee JH; Kim MS; Kim SH; Lu J
Cancer Res; 2006 Jan; 66(1):453-63. PubMed ID: 16397261
[TBL] [Abstract][Full Text] [Related]
9. Nanocomposites based on Soluplus and Angelica gigas Nakai extract fabricated by an electrohydrodynamic method for oral administration.
Lee JJ; Nam S; Park JH; Lee SY; Jeong JY; Lee JY; Kang WS; Yoon IS; Kim DD; Cho HJ
J Colloid Interface Sci; 2016 Dec; 484():146-154. PubMed ID: 27599383
[TBL] [Abstract][Full Text] [Related]
10. Decursin and decursinol from Angelica gigas inhibit the lung metastasis of murine colon carcinoma.
Son SH; Park KK; Park SK; Kim YC; Kim YS; Lee SK; Chung WY
Phytother Res; 2011 Jul; 25(7):959-64. PubMed ID: 21170925
[TBL] [Abstract][Full Text] [Related]
11. Anti-tumor activities of decursinol angelate and decursin from Angelica gigas.
Lee S; Lee YS; Jung SH; Shin KH; Kim BK; Kang SS
Arch Pharm Res; 2003 Sep; 26(9):727-30. PubMed ID: 14560921
[TBL] [Abstract][Full Text] [Related]
12. Effects of Decursin and
Lee TK; Kim B; Kim DW; Ahn JH; Sim H; Lee JC; Yang GE; Her Y; Park JH; Kim HS; Sim TH; Lee HS; Won MH
Molecules; 2020 Aug; 25(16):. PubMed ID: 32823713
[TBL] [Abstract][Full Text] [Related]
13. Decursin from Angelica gigas Nakai Inhibits B16F10 Melanoma Growth Through Induction of Apoptosis.
Kim BS; Seo H; Kim HJ; Bae SM; Son HN; Lee YJ; Ryu S; Park RW; Nam JO
J Med Food; 2015 Oct; 18(10):1121-7. PubMed ID: 26336081
[TBL] [Abstract][Full Text] [Related]
14. Cytochrome P450 Isoforms in the Metabolism of Decursin and Decursinol Angelate from Korean Angelica.
Zhang J; Li L; Tang S; Hale TW; Xing C; Jiang C; Lü J
Am J Chin Med; 2015; 43(6):1211-30. PubMed ID: 26394652
[TBL] [Abstract][Full Text] [Related]
15. Biopharmaceutical characterization of decursin and their derivatives for drug discovery.
Mahat B; Chae JW; Baek IH; Song GY; Song JS; Ma JY; Kwon KI
Drug Dev Ind Pharm; 2013 Oct; 39(10):1523-30. PubMed ID: 23003006
[TBL] [Abstract][Full Text] [Related]
16. Decursin from Angelica gigas mitigates amnesia induced by scopolamine in mice.
Kang SY; Lee KY; Park MJ; Kim YC; Markelonis GJ; Oh TH; Kim YC
Neurobiol Learn Mem; 2003 Jan; 79(1):11-8. PubMed ID: 12482674
[TBL] [Abstract][Full Text] [Related]
17. Omega-3 fatty acids incorporated colloidal systems for the delivery of Angelica gigas Nakai extract.
Lee JJ; Park JH; Lee JY; Jeong JY; Lee SY; Yoon IS; Kang WS; Kim DD; Cho HJ
Colloids Surf B Biointerfaces; 2016 Apr; 140():239-245. PubMed ID: 26764107
[TBL] [Abstract][Full Text] [Related]
18. Single oral dose pharmacokinetics of decursin and decursinol angelate in healthy adult men and women.
Zhang J; Li L; Hale TW; Chee W; Xing C; Jiang C; Lü J
PLoS One; 2015; 10(2):e0114992. PubMed ID: 25695490
[TBL] [Abstract][Full Text] [Related]
19. Decursin in Angelica gigas Nakai (AGN) Enhances Doxorubicin Chemosensitivity in NCI/ADR-RES Ovarian Cancer Cells via Inhibition of P-glycoprotein Expression.
Choi HS; Cho SG; Kim MK; Kim MS; Moon SH; Kim IH; Ko SG
Phytother Res; 2016 Dec; 30(12):2020-2026. PubMed ID: 27605402
[TBL] [Abstract][Full Text] [Related]
20. Decursin and decursinol inhibit VEGF-induced angiogenesis by blocking the activation of extracellular signal-regulated kinase and c-Jun N-terminal kinase.
Son SH; Kim MJ; Chung WY; Son JA; Kim YS; Kim YC; Kang SS; Lee SK; Park KK
Cancer Lett; 2009 Jul; 280(1):86-92. PubMed ID: 19307054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
